MTCM
XLRN

Mint Tower Capital Management’s Acceleron Pharma XLRN Stock Holding History

Mint Tower Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,000
Closed -$344K – 465
2021
Q3 		$344K Buy
+2,000
New +$262K 0.04% 245

Mint Tower Capital Management's XLRN Position: Q4 2021 in Review

Mint Tower Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,000 shares — an estimated $344K sold.

Mint Tower Capital Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $344K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Mint Tower Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Mint Tower Capital Management sold 2,000 Acceleron Pharma shares in Q4 2021, an estimated $344K.
  • Mint Tower Capital Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Mint Tower Capital Management's Acceleron Pharma position peaked at $344K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Mint Tower Capital Management's 13F filing for Q4 2021, filed 4 Feb 2022.